Genex Pharmaceutical, Inc.
GENX · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 32.8% | -2.1% | 6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 88.8% | 91.1% | 87.9% | 88% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 24.4% | 37% | 39.4% | 44.7% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 10.6% | 25.4% | 25.1% | 43.1% |
| EPS Diluted | 0.019 | 0.03 | 0.04 | 0.06 |
| % Growth | -36% | -25% | -33.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |